Lilly buys a near-billion dollars worth company and gets its prospective migraine drug back
Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…
Moberg Pharma’s New Skin Spray SKU will be sold in 3,900 Walmart stores and in over 1,500 Walgreens stores.
Hikma Pharmaceuticals’s US subsidiary Roxane Laboratories has received an approval from the US Food and Drug Administration for its Sodium…
Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, highcholesterol, diabetes and skin care, has appointed Christina Wood as Sales and Marketing Director.
Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.
Zealand Pharma has announced a $10 million milestone payment following Sanofi’s announcement of European Commission marketing authorization in Europe for…
Motif Bio, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, has granted a total of 1,500,000 options to…
Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.
Erytech Pharma’s new data supporting the second company’s product candidate ERY-MET will be presented at the 2017 Gastrointestinal Cancers Symposium…